Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150639 · ClinicalTrials.gov registry record
Vaginal Microbiome and IVF Pregnancy Outcome
A clinical trial of Vaginal Flora Imbalance, sponsored by Freya Biosciences ApS.
- Completed
- Registry status
- 301
- Enrollment target
- 1
- Study location
NCT05150639: Completed study of Vaginal Flora Imbalance, sponsored by Freya Biosciences ApS.
NCT05150639 is a study of Vaginal Flora Imbalance that has completed, run by Freya Biosciences ApS. The registered enrollment target is 301 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05150639, a study of Vaginal Flora Imbalance, has completed, sponsored by Freya Biosciences ApS.
- COMPLETED
- Registry status
- 301 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this prospective, observational study is to investigate the prevalence of vaginal dysbiosis among women undergoing IVF procedures in the US. And to investigate the associations between the vaginal microbiome and the pregnancy outcome following IVF.
Primary Outcome
The prevalence (evaluated as % of included population) of vaginal dysbiosis in women undergoing frozen embryo transfer IVF treatment in the US
Conditions Studied
Interventions
- OTHER IVF
Study Locations (1)
Massachusetts
- Boston IVF The Waltham Center - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2023-05-26 |
What the finished NCT05150639 record still lists
NCT05150639 is an observational study that tracks outcomes without assigning an intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Vaginal Flora Imbalance appearing as the primary indexed condition, and to 1 intervention - of which IVF is the first listed.
NCT05150639 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05150639 about?
NCT05150639 is a clinical study titled "Vaginal Microbiome and IVF Pregnancy Outcome". The aim of this prospective, observational study is to investigate the prevalence of vaginal dysbiosis among women undergoing IVF procedures in the US. And to investigate the associations between the vaginal microbiome and the pregnancy outcome following IVF.
What is the current status of trial NCT05150639?
This trial is currently completed. The enrollment target is 301 participants. The study started on 2022-03-18. Estimated completion is 2023-05-26.
What conditions does trial NCT05150639 study?
This clinical trial studies the following conditions: Vaginal Flora Imbalance.
What interventions are being tested in trial NCT05150639?
The interventions under investigation include: IVF (OTHER).
Who is sponsoring clinical trial NCT05150639?
This trial is sponsored by Freya Biosciences ApS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150639 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005975 · 301 participants · Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI